14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.11 $12.52 Wednesday, 1st May 2024 KALV stock ended at $12.18. This is 7.31% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 10.31% from a day low at $11.35 to a day high of $12.52.
90 days $10.11 $16.88
52 weeks $7.21 $16.88

Historical KalVista Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jun 08, 2023 $9.78 $10.07 $9.78 $9.99 183 709
Jun 07, 2023 $10.31 $10.42 $9.85 $9.88 192 532
Jun 06, 2023 $10.22 $10.48 $10.04 $10.34 170 276
Jun 05, 2023 $9.96 $10.23 $9.82 $10.18 252 276
Jun 02, 2023 $10.19 $10.26 $9.99 $10.00 138 980
Jun 01, 2023 $9.73 $10.24 $9.68 $10.08 190 589
May 31, 2023 $9.46 $9.80 $9.31 $9.75 121 866
May 30, 2023 $9.63 $9.76 $9.21 $9.32 138 413
May 26, 2023 $9.48 $9.86 $9.04 $9.48 246 723
May 25, 2023 $10.39 $10.39 $9.74 $9.76 154 237
May 24, 2023 $10.50 $10.67 $10.33 $10.38 217 601
May 23, 2023 $10.57 $10.95 $10.55 $10.57 163 576
May 22, 2023 $10.41 $10.61 $10.10 $10.57 320 290
May 19, 2023 $10.47 $10.76 $10.47 $10.53 157 103
May 18, 2023 $10.27 $10.43 $9.99 $10.40 485 079
May 17, 2023 $10.13 $10.40 $9.96 $10.29 224 271
May 16, 2023 $10.08 $10.15 $9.89 $10.05 229 471
May 15, 2023 $9.70 $10.35 $9.33 $10.11 156 447
May 12, 2023 $9.79 $9.83 $9.62 $9.79 102 930
May 11, 2023 $9.58 $9.76 $9.50 $9.73 101 884
May 10, 2023 $9.57 $9.88 $9.22 $9.73 184 379
May 09, 2023 $9.47 $9.55 $9.35 $9.42 87 489
May 08, 2023 $9.49 $9.65 $9.36 $9.54 302 117
May 05, 2023 $9.45 $9.65 $9.45 $9.62 161 137
May 04, 2023 $9.18 $9.40 $9.10 $9.34 141 464
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT